Prediction: Stocks That Will Outperform Summit in One Year
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesSpotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
Bold moves in the logistics space are reshaping Amazon’s growth story. This article breaks down what the latest annou...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
Planet Fitness posted a robust surge in revenue, but a large investor trimmed a substantial stake. This article break...
Investing in Micron today means evaluating AI-driven memory demand, pricing power, and the memory market cycle. This ...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
After years of setbacks, Intel appears to be turning a corner on its AI ambitions. This article breaks down what to w...
In July, investors are weighing recession risks against reliable income. This guide highlights three dividend staples...
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...
Despite rates at year-to-year highs, housing demand stays positive as weekly data on pending sales and mortgage appli...
A landmark Nvidia-backed investment could be a game changer for Nebius shareholders. This in-depth look breaks down w...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...